...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >An expeditious access to 5-pyrimidinol derivatives from cyclic methylglyoxal diadducts, formation of argpyrimidines under physiological conditions and discovery of new CFTR inhibitors.
【24h】

An expeditious access to 5-pyrimidinol derivatives from cyclic methylglyoxal diadducts, formation of argpyrimidines under physiological conditions and discovery of new CFTR inhibitors.

机译:可以从环状甲基乙二醛二加合物中快速获得5-嘧啶醇衍生物,在生理条件下形成精嘧啶,并发现新的CFTR抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

In the study of previously reported modulators of CFTR chloride channels that are cyclic methylglyoxal (MG) diadducts (CMGD) to aromatic alpha-aminoazaheterocycles, we optimized a new expeditious one pot route for preparing in water novel aromatic polycyclic azaheterocycles and described 5-pyrimidinols antioxidants through the formation of 2-oxoaldehyde diadducts to aromatic alpha-aminoazaheterocycles, amidines, guanidines and thiourea. In regard to the importance as biomarkers of diabetic complications of the 5-pyrimidinols argpyrimidines demonstrated that argpyrimidines are slowly formed under physiological conditions from CMGD to arginine derivatives according to the synthesis route described. Among the 5-pyrimidinol derivatives prepared, two polycyclic derivatives appeared to inhibit strongly the activity of CFTR channels in wt-CHO cells.
机译:在先前报道的CFTR氯化物通道调节剂的研究中,这些通道是环状甲基乙二醛(MGGD)加成芳香族α-氨基氮杂杂环的化合物,我们优化了一种新的快速一锅法,用于在水中制备新型芳香族多环氮杂杂环并描述了5-嘧啶类抗氧化剂通过形成2-氧醛二加成物形成芳族α-氨基氮杂环,idine,胍和硫脲。关于作为5-嘧啶醇的糖尿病并发症的生物标志物的重要性,精氨嘧啶表明,根据所述合成途径,在从CMGD到精氨酸衍生物的生理条件下,精氨嘧啶是缓慢形成的。在制备的5-嘧啶醇衍生物中,两种多环衍生物似乎强烈抑制wt-CHO细胞中CFTR通道的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号